[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2548664B1 - Derives 7-(pyrrol-l-yl) des acides l-ethyl-1,4-dihydro-4-oxoquinoleine-3-carboxyliques et l-ethyl-1,4-dihydro-4-oxo-(1,8-naphtyridine)-3-carboxyliques substitues, leur preparation et leur application en tant que medicaments - Google Patents

Derives 7-(pyrrol-l-yl) des acides l-ethyl-1,4-dihydro-4-oxoquinoleine-3-carboxyliques et l-ethyl-1,4-dihydro-4-oxo-(1,8-naphtyridine)-3-carboxyliques substitues, leur preparation et leur application en tant que medicaments

Info

Publication number
FR2548664B1
FR2548664B1 FR8311250A FR8311250A FR2548664B1 FR 2548664 B1 FR2548664 B1 FR 2548664B1 FR 8311250 A FR8311250 A FR 8311250A FR 8311250 A FR8311250 A FR 8311250A FR 2548664 B1 FR2548664 B1 FR 2548664B1
Authority
FR
France
Prior art keywords
dihydro
ethyl
oxoquinolein
naphtyridine
carboxylics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8311250A
Other languages
English (en)
Other versions
FR2548664A1 (fr
Inventor
Jose Esteve Soler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Provesan SA
Original Assignee
Provesan SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Provesan SA filed Critical Provesan SA
Priority to FR8311250A priority Critical patent/FR2548664B1/fr
Priority to FR8402145A priority patent/FR2559484B2/fr
Priority to AU29425/84A priority patent/AU564326B2/en
Priority to US06/622,647 priority patent/US4552882A/en
Priority to ZA844693A priority patent/ZA844693B/xx
Priority to CA000457471A priority patent/CA1256876A/fr
Priority to ES533749A priority patent/ES533749A0/es
Priority to MX201827A priority patent/MX156436A/es
Priority to EP84401391A priority patent/EP0134165B1/fr
Priority to AT84401391T priority patent/ATE34982T1/de
Priority to DE8484401391T priority patent/DE3471934D1/de
Priority to GR75174A priority patent/GR81646B/el
Priority to IN536/DEL/84A priority patent/IN161611B/en
Priority to RO115120A priority patent/RO88915B/ro
Priority to PL1984248545A priority patent/PL143730B1/pl
Priority to NO842717A priority patent/NO163329C/no
Priority to JP59138851A priority patent/JPS6036482A/ja
Priority to HU842641A priority patent/HU189916B/hu
Priority to PT78854A priority patent/PT78854B/fr
Priority to BR8403342A priority patent/BR8403342A/pt
Priority to SU843759901A priority patent/SU1322980A3/ru
Priority to DK331384A priority patent/DK163126C/da
Priority to DD84264967A priority patent/DD223150A5/de
Priority to KR1019840003918A priority patent/KR880002355B1/ko
Priority to CS845285A priority patent/CS244139B2/cs
Priority to YU1190/84A priority patent/YU43577B/xx
Publication of FR2548664A1 publication Critical patent/FR2548664A1/fr
Application granted granted Critical
Publication of FR2548664B1 publication Critical patent/FR2548664B1/fr
Priority to HK104/91A priority patent/HK10491A/xx
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR8311250A 1983-07-06 1983-07-06 Derives 7-(pyrrol-l-yl) des acides l-ethyl-1,4-dihydro-4-oxoquinoleine-3-carboxyliques et l-ethyl-1,4-dihydro-4-oxo-(1,8-naphtyridine)-3-carboxyliques substitues, leur preparation et leur application en tant que medicaments Expired FR2548664B1 (fr)

Priority Applications (27)

Application Number Priority Date Filing Date Title
FR8311250A FR2548664B1 (fr) 1983-07-06 1983-07-06 Derives 7-(pyrrol-l-yl) des acides l-ethyl-1,4-dihydro-4-oxoquinoleine-3-carboxyliques et l-ethyl-1,4-dihydro-4-oxo-(1,8-naphtyridine)-3-carboxyliques substitues, leur preparation et leur application en tant que medicaments
FR8402145A FR2559484B2 (fr) 1983-07-06 1984-02-13 Nouveau derive 7-(pyrrol-1-yl) de l'acide 1-ethyl-1,4-dihydro-4-oxo-(1,8-naphtyridin)-3-carboxylique, sa preparation et son application en tant que medicament
AU29425/84A AU564326B2 (en) 1983-07-06 1984-06-15 1,4-dihydro-quinoline and 1,4-dihydro-1,8-naphthyridine derivatives
US06/622,647 US4552882A (en) 1983-07-06 1984-06-20 7-(1-Pyrrolyl) derivatives of 1-ethyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acids and 1-ethyl-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acids and their use as antimicrobial agents
ZA844693A ZA844693B (en) 1983-07-06 1984-06-21 7-(1-pyrrolyl)derivatives of substituted 1-ethyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acids and substituted 1-ethyl-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acids,their preparation and their application as drugs
CA000457471A CA1256876A (fr) 1983-07-06 1984-06-26 Derives 7-(1-pyrrolyl) d'acides 1-ethyl-1,4- dihydro-4-oxoquinoleine-3-carboxyliques substitues et d'acides l-ethyl-1,4-dihydro-4-oxo-1,8- naphtyridine-3-carboxyliques substitues; preparation et utilisation comme medicaments
ES533749A ES533749A0 (es) 1983-07-06 1984-06-27 Procedimiento de preparar derivados de acidos carboxilicos
MX201827A MX156436A (es) 1983-07-06 1984-06-28 Procedimiento para preparar derivados de 7-(pirrol-1-il) de los acidos -1-etil-1, 4-dihidro -4-oxoquinolein-3-carboxilico y 1-etil-1, 4-dihdro -4-oxo-(1,8-naftiridin)-3-carboxilico substituidos
AT84401391T ATE34982T1 (de) 1983-07-06 1984-06-29 7-(pyrrol-1-yl)-1-ethyl-1,4-dihydro-4-oxochinol n-3-carbonsaeure-derivate und 7-(pyrrol-1-yl)-1ethyl-1,4-dihydro-4-oxo-1,8-naphtyridin-3carbons|ure-derivate, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel.
DE8484401391T DE3471934D1 (en) 1983-07-06 1984-06-29 7-(pyrrol-1-yl)-1-ethyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid and 7-(pyrrol-1-yl)-1-ethyl-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid derivatives, their preparation and use as medicaments
EP84401391A EP0134165B1 (fr) 1983-07-06 1984-06-29 Dérivés 7-(pyrrol-1-yl) des acides 1-éthyl-1,4-dihydro-4-oxoquinoléine-3-carboxyliques et 1-éthyl-1,4-dihydro-4-oxo-(1,8-naphtyridine)-3-carboxyliques substitués, leur préparation et leur application en tant que médicaments
PL1984248545A PL143730B1 (en) 1983-07-06 1984-07-03 Process for preparing derivatives of 7-/pyrrolyl-1-/-1-ethyl-1,4-dihydro-4-ketoquinoline-/or-4-keto-1,8-naphtiridine/-3-carboxylic acid
IN536/DEL/84A IN161611B (fr) 1983-07-06 1984-07-03
RO115120A RO88915B (ro) 1983-07-06 1984-07-03 Procedeu pentru prepararea unor derivati ai acizilor 1-etil-1, 4-di?idro-4-oxo-xhinolin-3-carboxilic si 1-etil-1, 4-dihidro-4-oxo-1, 8-naftiridin-3-carboxilic
GR75174A GR81646B (fr) 1983-07-06 1984-07-03
JP59138851A JPS6036482A (ja) 1983-07-06 1984-07-04 ７‐（１‐ピロリル）‐１‐エチル‐１，４‐ジヒドロ‐４‐オキソキノリン‐３‐カルボン酸及び７‐（１‐ピロリル）‐１‐エチル‐１，４‐ジヒドロ‐４‐オキソ‐１，８‐ナフチリジン‐３‐カルボン酸誘導体、これらの製法及び医薬
NO842717A NO163329C (no) 1983-07-06 1984-07-04 Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 7-(pyrrol-1-yl)-1-etyl-1,4-dihydro-4-okso-kinolin-3-karboksylsyre og 7-(pyrrol-1-yl)-1-etyl-1,4-dihydro-4-okso-(1,8-naftyridin)-3-karboksylsyre.
SU843759901A SU1322980A3 (ru) 1983-07-06 1984-07-05 Способ получени производных 7-(пиррол-1-ил)-1-этил-1,4-дигидро-4-оксохинолеин-3-карбоновой и 7-(пиррол-1-ил)-1-этил-1,4-дигидро-4-оксо-(1,8-нафтиридин)-3-карбоновой кислот
BR8403342A BR8403342A (pt) 1983-07-06 1984-07-05 Derivados dos acidos 7-(pirrol-1-il)-1-etil-1,4-di-hidro-4-oxo-quinoleina-3-carbonoxilico e 7-(pirrol-1-il)-1-etil-1,4-di-hidro-4-oxo(1,8-naftiridin)-3-carboxilico,processo de preparacao e composicoes farmaceuticas
HU842641A HU189916B (en) 1983-07-06 1984-07-05 Process for production of substituated-1-ethil-1,4-dihydro-4-oxo-kinolin-3-carboxylic acids and 7-/l-pirolil/-derivates of 1-ethil-1,4-dihydro-4-oxo-1,8-naftiridin-3-carboxylic acids and medical preparates consisting of such compounds
DK331384A DK163126C (da) 1983-07-06 1984-07-05 1-ethyl-1,4-dihydro-4-oxo-3-carboxy-quinolin- eller -(1,8-naphthyridin)-derivater, fremgangsmaade til fremstilling deraf, farmaceutiske praeparater indeholdende disse samt udgangsmateriale til brug ved fremgangsmaaden
DD84264967A DD223150A5 (de) 1983-07-06 1984-07-05 Verfahren zur herstellung von 7-(pyrrol-1-yl)-derivaten der substituierten 1-ethyl-1,4-dihydro-4-oxochinolin-3-carboxylsaeure
PT78854A PT78854B (fr) 1983-07-06 1984-07-05 Procede de preparation de derives 7-(pyrrol-1-yl)des acides 1-ethyl-1,4-dihydro-4-oxoquinoleine-3-carboxiliques et 1-ethyl-1,4-dihydro-4-oxo-(1,8-naphtyridine)-3-carboxiliques substitues et de compositions pharmaceutiques les contenant
KR1019840003918A KR880002355B1 (ko) 1983-07-06 1984-07-06 카복실산 유도체의 제조방법
CS845285A CS244139B2 (en) 1983-07-06 1984-07-06 Method of 7-(1-pyrrolyl)-1-ethyl-1,4-dihydro-4-oxoquinoline-3-carboxyl acid's and 7(1-pyrrolyl)-1-ethyl-1,4-dihydro-4-oxo-1,8-naphthyridin-3-carboxyl acid's derivatives production
YU1190/84A YU43577B (en) 1983-07-06 1984-07-06 Process for making derivatives of 7-(pyrol-1-il) 1-ethyl-1,4-dihydro-4-oxo-1,8-naphtyridine-3-carbonic acid
HK104/91A HK10491A (en) 1983-07-06 1991-02-06 7-(pyrrol-1-yl)-1-ethyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid and 7-(pyrrol-1-yl)-1-ethyl-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid derivatives,their preparation and use as medicaments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8311250A FR2548664B1 (fr) 1983-07-06 1983-07-06 Derives 7-(pyrrol-l-yl) des acides l-ethyl-1,4-dihydro-4-oxoquinoleine-3-carboxyliques et l-ethyl-1,4-dihydro-4-oxo-(1,8-naphtyridine)-3-carboxyliques substitues, leur preparation et leur application en tant que medicaments

Publications (2)

Publication Number Publication Date
FR2548664A1 FR2548664A1 (fr) 1985-01-11
FR2548664B1 true FR2548664B1 (fr) 1986-03-21

Family

ID=9290571

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8311250A Expired FR2548664B1 (fr) 1983-07-06 1983-07-06 Derives 7-(pyrrol-l-yl) des acides l-ethyl-1,4-dihydro-4-oxoquinoleine-3-carboxyliques et l-ethyl-1,4-dihydro-4-oxo-(1,8-naphtyridine)-3-carboxyliques substitues, leur preparation et leur application en tant que medicaments

Country Status (6)

Country Link
JP (1) JPS6036482A (fr)
FR (1) FR2548664B1 (fr)
IN (1) IN161611B (fr)
RO (1) RO88915B (fr)
SU (1) SU1322980A3 (fr)
ZA (1) ZA844693B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1221492B (it) * 1984-03-13 1990-07-06 Biochem Design Srl Acidi 7-(1-pirril)-e 7-(1-pirroli-dinil)-6-fluoro-1-etil-1,4-diidro-4-chetochinolin-3-carbossilici ad attivita' antimicrobiche,loro procedimento di preparazione e composti farmaceutici che li contengono
EP2275141A1 (fr) 1999-03-17 2011-01-19 Daiichi Pharmaceutical Co., Ltd. Compositions pharmaceutiques au gout camoufle

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU168497B (fr) * 1972-12-18 1976-05-28
JPS5233694A (en) * 1975-09-09 1977-03-14 Dai Ichi Seiyaku Co Ltd Process for preparation of 6_nitro-1,8-naphthyridine derivatives
AR223983A1 (es) * 1978-08-25 1981-10-15 Dainippon Pharmaceutical Co Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico

Also Published As

Publication number Publication date
IN161611B (fr) 1988-01-02
JPH026756B2 (fr) 1990-02-13
SU1322980A3 (ru) 1987-07-07
RO88915A (fr) 1987-06-30
JPS6036482A (ja) 1985-02-25
RO88915B (ro) 1987-07-01
FR2548664A1 (fr) 1985-01-11
ZA844693B (en) 1985-02-27

Similar Documents

Publication Publication Date Title
FR2634483B2 (fr) Derives des acides 7-(1-azetidinyl)-1,4-dihydro-4-oxoquinoleine-3-carboxyliques, leur preparation et leur application en tant que medicaments
AU547849B2 (en) Quinoline carboxamides and their derivatives
NO844845L (no) Derivater av 2,2`-iminobisetanol
BE861453A (fr) Derives acyles substitues d'amino-acides, leur preparation et leur utilisation
CS409491A3 (en) Derivatives of amino acids, process of their preparation, agents comprising said compounds and their application
NO880740D0 (no) Fremgangsmaate for fremstilling av mettede heterocykliske carboxamidderivater.
NO862661L (no) Fremgangsmaate for fremstilling av n-aralkylpiperidinmethanolderivater.
NO875378L (no) Fremgangsmaate for fremstilling av granulocyttstimulerendefaktor (polypeptidderivater).
NO883007D0 (no) Fremgangsmaate for fremstilling av benzopyran-derivater.
NO861956L (no) Fremgangsmaate for fremstilling av askorbinsyrederivater.
FR2493845B1 (fr) Derives de benzofuranne-2 substitues utiles comme medicaments et procedes de preparation
IT8322591A0 (it) Derivati di acidi amminati, loro preparazione, loro impiego e anche composizioni che contengono questi derivati.
IT8567500A0 (it) Derivati di 1 3 ossazolidin 2 one e procedimenti per la loro preparazione
FR2548664B1 (fr) Derives 7-(pyrrol-l-yl) des acides l-ethyl-1,4-dihydro-4-oxoquinoleine-3-carboxyliques et l-ethyl-1,4-dihydro-4-oxo-(1,8-naphtyridine)-3-carboxyliques substitues, leur preparation et leur application en tant que medicaments
NO880294D0 (no) Fremgangsmaate for fremstilling av tetrahydrofuranderivater
DK311484D0 (da) Vandoploeselige rifampicinderivater og fremgangsmaade til fremstilling deraf
NO845148L (no) Fremgangsmaate for fremstilling av 16-fenoksy- og 16-substituert-fenoksy-prostatrinsyre-derivater
IT8048996A0 (it) Derivati di acidi alcanoici dotati di proprieta' terapeutiche e procedimento per la loro preparazione
EP0203528A3 (en) Cyclopentene derivatives and their use as odorants
PT86933A (pt) Process for the preparation pf optically active oxo-isoindolinyul derivatives and of pharmaceutical compositions containing the same
FR2330400A1 (fr) Derives d'acides pyrimidine-7-carboxyliques substitues, leur preparation et leurs utilisations therapeutiques
FR2531084B1 (fr) Nouveaux derives de la 7-(4-pyridyl)-1,8-naphtyridine, medicament et compositions pharmaceutiques en contenant
FR2499571B1 (fr) Nouveaux derives d'apovincaminol, leur preparation et leur application en tant que medicaments
MA19461A1 (fr) Nouveaux derives d'aminoethoxy-4 isopropyl-5 methyl-2, leur methode de preparation et leur emploi en tant que medicaments
IT1218225B (it) Derivati del bisbenzotrifluoruro e metodo di preparazione degli stessi

Legal Events

Date Code Title Description
ST Notification of lapse